Tailored radiation beams show promise against tough liver tumors
NCT ID NCT03896646
First seen Nov 21, 2025 · Last updated Apr 28, 2026 · Updated 27 times
Summary
This study tests whether giving a personalized dose of radiation (Y-90) to liver cancer patients can shrink tumors better than standard dosing. The approach uses individual patient scans to plan the exact amount of radiation needed. The trial includes 42 adults with advanced liver cancer that cannot be removed by surgery. The goal is to improve tumor response while keeping the healthy liver safe.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE III HEPATOCELLULAR CARCINOMA AJCC V8 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.